Martine E D Chamuleau

18PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical devicesChemical engineering designMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 12, 2025
Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Steven Wang, Marcel Nijland, Leonie Strobbe

|Oct 06, 2025
Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL.

Hilma J van der Horst, Tamás Csikós, Marjolein Quik

|Jul 08, 2025
Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability-enhancing strategies.

Daan W Huntjens, Olivier J M Béquignon, Stefanie D Krens

|Jun 29, 2025
Reply to: 'Methotrexate toxicity and glucarpidase: A call for dose optimization'.

Arjen Koppen, Maaike A Sikma, Frederike K Engels

|Mar 12, 2025
Methotrexate toxicity and glucarpidase: A call for dose optimization.

Arjen Koppen, Maaike A Sikma, Frederike K Engels

|Nov 27, 2024
Delineating MYC-Mediated Escape Mechanisms from Conventional and T Cell-Redirecting Therapeutic Antibodies.

Anna Vera de Jonge, Tamás Csikós, Merve Eken

Pageof 3